Skip to main content
. 2020 Jul 15;20(4):14. doi: 10.3892/ol.2020.11875

Table V.

Development of irAEs and unexpected critical complications among the three subgroups of frailty (age <75 years).

Variables Low frailty (FS=0) (n=75), n (%) Intermediate frailty (FS=1) (n=51), n (%) High frailty (FS=2, 3) (n=13), n (%) P-value
Total of irAEs 35 (46.7) 15 (29.4) 2 (15.4) 0.09
Grade 3–5 irAEs 5 (6.7) 5 (9.8) 2 (15.4) 0.55
Unexpected critical complications Worsening of preexisting dermatomyositis (n=1) None None

irAEs, immune related adverse events; FS, frailty score.